Impactful Connections and Intelligence
The global biopharmaceutical industry's one-stop shop of market intelligence and business connections.
Introducing the APAC Bioprocessing Dashboard
A quick-view bioprocessing data & analytics tool with Validated. Quality Data. On A Single Platform.
0
Connections
0
Conventions
0
Clients
0
Countries
0
Children Sent to School
Explore Our Services
B2B EVENTS
Thought leadership, industry knowledge-sharing and quality networking are at the core of IMAPAC's B2B events.
MARKET INTELLIGENCE
Data driven decisions to help organizations grow. In-depth biopharmaceutical industry intelligence brought to you by our team of analysts; fully customizable to your requirements.
LEADGEN 360
Expand your influence, be it through branding & display ads, content creation or thought leadership.
Latest News
May 24, 2022
Becton Dickinson & Company (BD) Bags IMAPAC’s Asia Bioprocessing Excellence Award 2022 and Recognized as The Best Bioprocessing Supplier Award: Formulation & Delivery Innovation
SINGAPORE – IMAPAC – 31 March 2022 BD, one of the largest global medical technology companies, has bagged the Asia Bioprocessing Excellence Award (ABEA) 2022 under the category Bioprocessing Supplier Award: Formulation & Delivery Innovation. The ABEA 2022 Ceremony was held in conjunction with the 9th Biologics Manufacturing Asia and 6th Biologistics World Asia 2022 […]
Moderna files for authorization of its COVID-19 Vaccine in young children six months to under six years of age
Excerpt Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced today that it has submitted an emergency use authorization (EUA) request to the US Food and Drug Administration for its COVID-19 vaccine (mRNA-1273) in children aged 6 months to under 2 years and 2 years to under 6 years, as well […]
May 24, 2022
Vienna Airport sees pharma volumes grow as Austrian signs up to VPHC
Excerpt: Austrian Airlines has signed up to use the Vienna Airport Pharma Handling Center (VPHC) for all of its cargo volumes at the Austrian airport. Vienna Airport said the deal with the Lufthansa Group-owned airline would further establish the airport as a pharma hub for central and eastern Europe. Article Summary: Vienna airport said […]
May 24, 2022
Vertex Announces Plan to Expand Cell and Gene Therapy Footprint
Excerpt Vertex Pharmaceuticals Incorporated has announced plans to set up another 344,000 sq ft facility in the Seaport to support the company’s continued rapid growth of its cell and genetic therapies programs. Article Summary The completion of the new site at Seaport is expected in 2025 following which Vertex will occupy 1.9 million square feet […]
May 24, 2022
Hear from Our Clients
Thank you again for producing this really successful and relevant conference. I enjoyed expert conversations with outstanding people and network opportunities were excellent.
Samsung Engineering
South Korea
Excellent event with good knowledge sharing by experienced scientists globally to combat present situation and challenges faced by the vaccine manufacturing industry. Kind hospitality by IMAPAC...Keep it up.
Hester Biosciences Limited
India
Talks were very interesting addressing subjects really important such as the balance of Th1 and Th2 cells as immune response of COVID-19 vaccines. I have achieved a lot watching and rewatching the videos too.
Instituto Butantan
Brazil
It’s my pleasure to be a participant in IMAPAC's 11th World Vaccine summit. This virtual platform supported in exploring more on the current trends on vaccine developments from various manufacturers/ research centers.
BravoVax
China
